Related Experiment Video

Updated: May 8, 2026

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy
10:10

Quantifying Cognitive Decrements Caused by Cranial Radiotherapy

Published on: October 18, 2011

Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication

Anna Luisa Di Stefano1, Giulia Berzero, Paolo Vitali

  • 1From C. Mondino National Institute of Neurology Foundation (A.L.D., G.B., P.V., C.A.G., M.C., S.B., L.D., E.M.), IRCCS, Pavia, Italy; Neuroscience Consortium (G.B., L.D.), University of Pavia, Monza Policlinico and Pavia Mondino, Italy; Department of Neuro-oncology (F.D.), Hospices Civils de Lyon, Lyon Neuroscience Research Center INSERM U1028/CNRS UMR 5292, Université Claude Bernard Lyon, France; Department of Neuroscience (M.C., S.B.), University of Pavia, Italy; Bone Marrow Transplant Unit (A.A.C.), Department of Hematology Oncology, Foundation IRCCS, Policlinico San Matteo, Pavia, Italy; C.O.U. of Diagnostic Radiology and Interventional Radiology and Neuroradiology (A. Simoncelli), IRCCS Policlinico S. Matteo Foundation, Pavia, Italy; Department of Neurology (M.C.B., B.G.), Ospedale Ca' Foncello, Treviso, Italy; Neuro-oncology Unit (P.G., A. Silvani), Neurological Institute C. Besta, Milan, Italy; and SC Neurologia (A. Salmaggi), Ospedale A. Manzoni, Lecco, Italy.

Neurology
|August 13, 2013
PubMed

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Related Concept Videos

Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...